AH 7614
CAS No. 6326-06-3
AH 7614( —— )
Catalog No. M24637 CAS No. 6326-06-3
AH 7614 is a selective and potent free fatty acid receptor 4 (FFA4/GPR120) antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 75 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 401 | In Stock |
|
| 200MG | 522 | In Stock |
|
| 500MG | 678 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAH 7614
-
NoteResearch use only, not for human use.
-
Brief DescriptionAH 7614 is a selective and potent free fatty acid receptor 4 (FFA4/GPR120) antagonist.
-
DescriptionAH 7614 is a selective and potent free fatty acid receptor 4 (FFA4/GPR120) antagonist.
-
In VitroAH-7614 (compound 39) (0.063-1 μM) blocks intracellular Ca2+ response induced by both linoleic acid and FFAR4 agonist in FFA4 expressing U2OS cells.?AH-7614 (100 μM) abolishes the enhancement in glucose-stimulated insulin secretion by GSK137647A in NCI-H716 cells.AH-7614 (0.001-10 μM; 15 min) blocks TUG-891-mediated internalization of FFA4 from the cell surface (pIC50=7.70).AH-7614 (10 μM; 30 min) blocks agonist-induced elevation of intracellular inositol monophosphates and phosphorylation of FFA4.
-
In VivoAH7614 (50μg; intratumoral injection once every 4?d for 20 d) reduces the tumor growth in mice.AH7614 (50μg; intratumoral injection one day prior to epirubicin injection) enhances cancer cell sensitivity to the chemotherapy and inhibit tumor progression by blocking GPR120 signaling in combination with Epirubicin.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR120
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6326-06-3
-
Formula Weight351.42
-
Molecular FormulaC20H17NO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:35.1 mg/mL(100 mM);Ethanol:Insoluble;Water:Insoluble
-
SMILESO=S(C1=CC=C(C)C=C1)(NC2C3=C(OC4=C2C=CC=C4)C=CC=C3)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, et al. Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). Bioorg Med Chem Lett. 2014;24(14):3100-3.
molnova catalog
related products
-
2-(pentylsulfanyl)py...
2-(pentylsulfanyl)pyrimidine-4,6-diol is a novel GRP84 agonist.
-
TUG-499
TUG-499 is a selective free fatty acid receptor 1 (FFAR1 or GPR40) agonist (EC50: 7.39).
-
hGPR91 antagonist 1
hGPR91 antagonist 1 is a potent and selective hGPR91 antagonist (IC50: 7 μM).GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.?Current literature indicates that GPR91 plays role in various pathophysiology including renal hypertension, autoimmune disease and retinal angiogenesis.?
Cart
sales@molnova.com